Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: richardred who wrote (1814)	4/27/2005 4:38:10 PM
From: arnie h	Read Replies (2) \| Respond to of 2173

At the least, his trading pattern doesn't inspire confidence in his outlook for the future. One would question why a company would want to have principal leaders who keep exercising and selling even small options at significant times. The only thing I can come up with is they fully expect to get Exenatide approval; otherwise the sleazy class action lawyers could swing into action. That tends to divert attention from the real purposes of the company even if there isn't much of a case.